Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLymphomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLymphomaTeam Member asked a question in Side Effects group 💭
Michigan Center, MI
November 4
 · 
Be the first to react
MyLymphomaTeam

Brukinsa (zanubrutinib) is a kinase inhibitor approved to treat Waldenström's macroglobulinemia (WM). Here's a breakdown of its side effects:

Common side effects
- Low white blood cell (neutrophil) count
- Low platelet count
- Upper respiratory tract infections
- Bleeding or bruising
- Musculoskeletal pain
- Anemia
- Rash
- Show Full Answer

Brukinsa (zanubrutinib) is a kinase inhibitor approved to treat Waldenström's macroglobulinemia (WM). Here's a breakdown of its side effects:

Common side effects:
- Low white blood cell (neutrophil) count
- Low platelet count
- Upper respiratory tract infections
- Bleeding or bruising
- Musculoskeletal pain
- Anemia
- Rash
- Diarrhea
- Cough

Rare but serious side effects:
- Significant bleeding problems
- Severe infections
- Heart rhythm problems
- Liver damage
- Secondary cancers (such as skin carcinomas)
- Harm to an unborn baby if taken during pregnancy It's really important to report any new or worsening symptoms to your care team as soon as possible, especially signs of bleeding, infection (like fever or chills), or irregular heartbeat. Your doctor can help manage side effects and adjust treatment if needed.

November 4

Related Questions

View All
A MyLymphomaTeam Member asked a question 💭
Cincinnati, OH